Protara Therapeutics, Inc. (TARA) Nonoperating Income (Expense) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protara Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2024.
  • Protara Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $756 K, a 10% increase year-over-year.
  • Protara Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $3.26 M, a 94.4% increase year-over-year.
  • Protara Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $3.19 M, a 188% increase from 2022.
  • Protara Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.11 M, a 368% increase from 2021.
  • Protara Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $237 K, a 49.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.26 M $756 K +$69 K +10% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $3.19 M $820 K +$278 K +51.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $2.92 M $840 K +$557 K +197% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $2.36 M $846 K +$680 K +410% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.68 M $687 K +$568 K +477% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.11 M $542 K +$483 K +819% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $627 K $283 K +$230 K +434% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $397 K $166 K +$156 K +1560% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $241 K $119 K +$4 K +3.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $237 K $59 K -$89 K -60.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $326 K $53 K -$39 K -42.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $365 K $10 K -$116 K -92.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $481 K $115 K +$15 K +15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $466 K $148 K +$118 K +393% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $348 K $92 K +$37 K +67.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $311 K $126 K +$55 K +77.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $256 K $100 K -$6 K -5.66% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $262 K $30 K -$96 K -76.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-20
Q3 2019 $358 K $55 K -$57 K -50.9% Jul 1, 2019 Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $415 K $71 K -$50 K -41.3% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $465 K $106 K -$178 K -62.7% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $643 K $126 K +$87 K +223% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $556 K $112 K +$113 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $443 K $121 K -$257 K -68% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $700 K $284 K +$302 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $398 K $39 K +$135 K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 $263 K -$1 K -$60 K -102% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $323 K $378 K +$429 K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$106 K -$18 K -$285 K -107% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $179 K -$96 K +$59 K +38.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 $120 K $59 K +$360 K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$240 K -$51 K +$40 K +44% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$280 K $267 K +$227 K +568% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$507 K -$155 K -$10.7 M -101% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $10.2 M -$301 K +$5.01 M +94.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $5.14 M -$91 K -$36 K -65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $5.18 M $40 K +$938 K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $4.24 M $10.5 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$5.32 M -$5.3 M -29428% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$55 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$898 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$18 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.